Trifecta Research Study
NCT07717866 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2026-07-21
Summary
This observational study evaluates the impact of Ibogaine-Magnesium (IM), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), Magnetic e-Resonance Therapy (MeRT), and Physiological Supplementation (PS) on posttraumatic stress disorder (PTSD) and traumatic brain injury-related cognitive symptoms among Special Operations Forces (SOF) combat veterans.
Conditions
- PTSD - Post Traumatic Stress Disorder
- Cognitive Dysfunction
- Brain Injury
- Depression - Major Depressive Disorder
- Suicidal Ideation
Interventions
- DEVICE
-
Magnetic e-Resonance Therapy (MeRT)
MeRT, an electroencephalography (EEG)-guided Repetitive Transcranial Magnetic Stimulation therapy, is a non-invasive treatment that uses magnetic pulses to modulate neural networks of the brain, guided by an individual's brain patterns. MeRT is a neuromodulatory tool that has shown therapeutic efficacy in relation to decreasing severity of PTSD symptoms. There is preliminary data showing MeRT's therapeutic impact on depression and TBI-related cognitive impairment through promoting cortical excitability, modulating neurotransmission, and restoring neuroplasticity.
- DRUG
-
Ibogaine Hydrochloride with Magnesium Sulfate
Ibogaine hydrochloride was administered orally. Ibogaine is an indole alkaloid that together with its metabolites interacts with mu opioid, kappa opioid, N-methyl-D-aspartate receptor (NMDA), and nicotinic acetylcholine receptors. Ibogaine has shown early signs of effectiveness as a rapid-acting treatment for a number of mental health disorders including PTSD and substance use disorder. Magnesium sulfate was administered intravenously prior to Ibogaine administration and orally each day.
- DRUG
-
5-methoxy-N,N-dimethyltryptamine
5-MeO-DMT is administered by using a pipe to inhale a vapor that is produced by heating a canister containing a powder form of the substance. 5-MeO-DMT is a 5-HT-1A and 5-HT-2A agonist compound that has shown early signs of effectiveness in treating depression. Inhaled 5-MeO-DMT has a short duration of action, producing an intense, time-limited psychoactive state.
- DRUG
-
Physiological Supplementation
Physiological Supplementation describes a treatment program aimed at restoring healthy endocrine functioning, using supplements such as the following: Synthetic testosterone, Anastrozole, Gonadorelin, Vitamin and amino acid supplementation, Fish oil, Ipamorelin.
Sponsors & Collaborators
-
Axial Therapeutic Research
lead INDUSTRY
Principal Investigators
-
I S Kroop · Axial Therapeutic Research
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2026-02-01
- Completion
- 2026-11-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation
NCT04325087 ·Status: UNKNOWN ·Phase: NA
-
Mechanism of Non-invasive Magnetic Stimulation
NCT03394066 ·Status: RECRUITING ·Phase: NA
-
TMS for Suicidal Crisis in Active Duty SMs
NCT03014362 ·Status: COMPLETED ·Phase: NA
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
NCT06413173 ·Status: RECRUITING ·Phase: NA
-
Effect of TMS on PTSD Biomarkers
NCT04563078 ·Status: COMPLETED ·Phase: NA
-
Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Chronic Posttraumatic Stress Disorder (PTSD)
NCT00001657 ·Status: COMPLETED
-
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD
NCT06608277 ·Status: RECRUITING ·Phase: PHASE2
-
rTMS to Improve Cognitive Function in TBI
NCT02152540 ·Status: COMPLETED ·Phase: NA
-
TMS for Improving Cognitive Function in Bipolar Disorder
NCT07414147 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Excitatory rTMS to the Left Dorsolateral Pre-Frontal Cortex to Reduce Cannabis-Cue Induced Craving
NCT02567344 ·Status: COMPLETED ·Phase: NA
-
Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury
NCT03844607 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
TMS - Intracranial Electrodes
NCT03702127 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Study of the Effect of Magnetic Stimulation Repetitive Transcranial on Impulsivity in Cocaine Dependence
NCT01397266 ·Status: UNKNOWN ·Phase: PHASE2
-
rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers
NCT04180969 ·Status: WITHDRAWN ·Phase: PHASE2
-
Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury
NCT05647044 ·Status: RECRUITING ·Phase: PHASE1
-
rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder
NCT05964777 ·Status: COMPLETED ·Phase: NA
-
fMRI-neuronavigated rTMS Treatment for Symptoms of Depression Associated With Concussive TBI in the Military Population
NCT03523507 ·Status: TERMINATED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
NCT02231892 ·Status: COMPLETED ·Phase: NA
-
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia
NCT07445620 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
rTMS Target Identification for Functional Disability in AUD+mTBI
NCT04043442 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in PTSD
NCT02873299 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment - RCT Trial
NCT05730296 ·Status: UNKNOWN ·Phase: NA
-
Electroencephalogram (EEG) Enhanced Transcranial Magnetic Stimulation (eTMS) for Chronic Trauma and Stressor-Related Disorders (TSRD)
NCT05835414 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The PREVENT Resilience Study
NCT07568145 ·Status: RECRUITING ·Phase: NA
-
Image-guided, Robotically Delivered Transcranial Magnetic Stimulation Treatment for Combat-Related Post-Traumatic Stress Disorder
NCT02853032 ·Status: COMPLETED ·Phase: NA